Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.64 |
| ▸ | ELANE | P08246 | 1/20 | 0.47 |
| ▸ | PTPN1 | P18031 | 6/20 | 0.44 |
| ▸ | STAT3 | P40763 | 6/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13461152 | 0.91 | L3MBTL1 (0.53) | L3MBTL1ELANEPTPN1STAT3MAPT | |
| Scandoside SCHEMBL29682452 | 0.84 | L3MBTL1 (0.61) | L3MBTL1ELANEPTPN1STAT3MAPT | |
| Scandoside SCHEMBL29426072 | 0.84 | L3MBTL1 (0.61) | L3MBTL1ELANEPTPN1STAT3MAPT | |
| Scandoside SCHEMBL307654 | 0.84 | L3MBTL1 (0.61) | L3MBTL1ELANEPTPN1STAT3MAPT | |
| SCHEMBL29425927 | 0.84 | ELANE (0.65) | L3MBTL1ELANEPTPN1STAT3MAPT | |
| SCHEMBL20572206 | 0.84 | ELANE (0.65) | L3MBTL1ELANEPTPN1STAT3MAPT | |
| SCHEMBL29425898 | 0.84 | ELANE (0.65) | L3MBTL1ELANEPTPN1STAT3MAPT | |
| SCHEMBL29896779 | 0.84 | ELANE (0.65) | L3MBTL1ELANEPTPN1STAT3MAPT | |
| Aucubin SCHEMBL22680274 | 0.78 | L3MBTL1 (1.00) | L3MBTL1ELANEPTPN1 | |
| Aucubin SCHEMBL22680275 | 0.78 | L3MBTL1 (1.00) | L3MBTL1ELANEPTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010030000-A1 | SKIN-WHITENING AGENT AND EXTERNAL SKIN PREPARATION FOR WHITENING OF SKIN | 学校法人 日本大学 (JP) | 2010-03-18 | — | — | WO | disclosed |